This underlines the conserved and critical function of the PGE2-EP2/EP4 axis in human cancer, and also supports the potential of EP2/EP4 expression analysis as a potential predictive biomarker for identification of patient populations that would especially benefit from EP2/EP4 receptor inhibition (210). This evidence concerns the gene PTGER2 and cancer.